[
 {
  "document": {
   "authors": "Abish K",
   "contact_info": "abish@causalitybiomodels.com",
   "copyright": "Copyright \u00a9 2020 Fraunhofer Institute SCAI, All rights reserved",
   "description": "COVID Knowledge Curation project",
   "licences": "Private Ownership to Fraunhofer Institute SCAI",
   "name": "32129518.bel",
   "version": "2.0.0"
  }
 },
 {
  "definitions": [
   {
    "namespace": {
     "keyword": "HGNC",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20190708.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "RGD",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/rgd-rat-genes/rgd-rat-genes-20190128.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "MESH",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh/mesh-names-20181007.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "TAX",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-taxonomy/ncbi-taxonomy-20200322.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "DO",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20200407.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "CHEBI",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "GO",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go/go-20180109.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "COVID",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-covid19/ncbi-covid19-20200326.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "UNIPROT",
     "type": "PATTERN",
     "value": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "PUBCHEM",
     "type": "PATTERN",
     "value": "^\\d+$",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Species",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/species-taxonomy-id/species-taxonomy-id-20170511.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "TextLocation",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "MeSHAnatomy",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20190128.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "MeSHDisease",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20190128.belanno",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Custom_Disease",
     "type": "LIST",
     "value": null,
     "value_list": [
      "COVID-19"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "Timeline",
     "type": "LIST",
     "value": null,
     "value_list": [
      "28 days"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "PublicationType",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Commentary"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "PublicationStatus",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Published"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "Section",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Abstract",
      "Full Text"
     ]
    }
   }
  ]
 },
 {
  "statements_and_sets": [
   {
    "sets": [
     {
      "citation": {
       "type": "PubMed",
       "title": "Drug Dev Res. 2020;10.1002/ddr.21656. doi:10.1002/ddr.21656",
       "ref": "32129518",
       "pub_date": "",
       "author_list": "",
       "comment": ""
      }
     },
     {
      "set": {
       "PublicationType": [
        "Commentary"
       ]
      }
     },
     {
      "set": {
       "PublicationStatus": [
        "Published"
       ]
      }
     },
     {
      "set": {
       "Section": [
        "Abstract"
       ]
      }
     },
     {
      "evidence": "A tentative suggestion based on existing therapeutics, which would likely be resistant to new coronavirus mutations, is to use available angiotensin receptor 1 (AT1R) blockers, such as losartan, as therapeutics for reducing the aggressiveness and mortality from SARS-CoV-2 virus infections."
     },
     {
      "set": {
       "Species": [
        "9606"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "losartan"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "AGTR1"
          }
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "losartan"
        }
       ]
      ]
     },
     {
      "relation": "is_a"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "angiotensin receptor antagonist"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "AGTR1"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "positive_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "This idea is based on observations that the angiotensin-converting enzyme 2 (ACE2) very likely serves as the binding site for SARS-CoV-2, the strain implicated in the current COVID-19 epidemic, similarly to strain SARS-CoV implicated in the 2002\u20132003 SARS epidemic."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "TAX",
            "name": "Severe acute respiratory syndrome coronavirus 2"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "HGNC",
            "name": "ACE2"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "TAX",
            "name": "Severe acute respiratory syndrome-related coronavirus"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "HGNC",
            "name": "ACE2"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "severe acute respiratory syndrome"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Section"
      ]
     },
     {
      "set": {
       "Section": [
        "Full Text"
       ]
      }
     },
     {
      "evidence": "A recent hypothesis suggested that angiotensin receptor 1 (AT1R) inhibitors might be beneficial for patients infected by COVID-19 who experience pneumonia (Sun, Yang, Sun, & Su, 2020)."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "angiotensin receptor antagonist"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "pneumonia"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "pneumonia"
        }
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "These tentative suggestions were based on the observation that SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) as the receptor binding domain for its spike protein (Lu et al., 2020; Wan, Shang, Graham, Baric, & Li, 2020), similarly to the coronavirus strain implicated in the 2002\u20132003 SARS epidemic (Dimitrov, 2003; Ge et al., 2013; Li et al., 2003; Prabakaran et al 2004; Turner, Hiscox, & Hooper, 2004)."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "S"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "HGNC",
            "name": "ACE2"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "COVID",
         "name": "S"
        }
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "TAX",
         "name": "Severe acute respiratory syndrome coronavirus 2"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "HGNC",
            "name": "ACE2"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "UNIPROT",
            "name": "P59594"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "severe acute respiratory syndrome"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "UNIPROT",
         "name": "P59594"
        }
       ]
      ]
     },
     {
      "relation": "association"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "TAX",
         "name": "Severe acute respiratory syndrome-related coronavirus"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "ACE cleaves angiotensin I to generate angiotensin II, the peptide which binds to and activates AT1R to constrict blood vessels, thereby elevating blood pressure."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "ACE"
          }
         ]
        ],
        {
         "namespace": null,
         "name": null,
         "default": "cat"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "transformation",
         "name": "reaction"
        }
       },
       [
        [
         {
          "function": {
           "type": "reaction_partner",
           "name": "reactants"
          }
         },
         [
          [
           {
            "function": {
             "type": "abundance",
             "name": "abundance"
            }
           },
           [
            {
             "namespace": "CHEBI",
             "name": "Angiotensin I"
            }
           ]
          ]
         ]
        ],
        [
         {
          "function": {
           "type": "reaction_partner",
           "name": "products"
          }
         },
         [
          [
           {
            "function": {
             "type": "abundance",
             "name": "abundance"
            }
           },
           [
            {
             "namespace": "CHEBI",
             "name": "angiotensin II"
            }
           ]
          ]
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "abundance"
           }
          },
          [
           {
            "namespace": "CHEBI",
            "name": "angiotensin II"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "HGNC",
            "name": "AGTR1"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "AGTR1"
          }
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "AGTR1"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "GO",
         "name": "vasoconstriction"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "GO",
         "name": "vasoconstriction"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Blood Pressure"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "By contract, ACE2 inactivates angiotensin II while generating angiotensin 1\u20137, a heptapeptide having a potent vasodilator function via activation of its Mas receptor (Santos et al., 2003), and thus serving as a negative regulator of the renin\u2013angiotensin system."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "ACE2"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "angiotensin II"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "ACE2"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "PUBCHEM",
         "name": "123805"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "PUBCHEM",
         "name": "123805"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "MAS1"
          }
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "MAS1"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "GO",
         "name": "vasodilation"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "ACE2"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Renin-Angiotensin System"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "The AT1R antagonists losartan and olmesartan, commonly applied for reducing blood pressure in hypertensive patients, were shown to increase cardiac ACE2 expression about three-fold following chronic treatment (28 days) after myocardial infarction induced by coronary artery ligation of rats (Ishiyama et al., 2004)."
     },
     {
      "set": {
       "MeSHDisease": [
        "Hypertension"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "losartan"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "AGTR1"
          }
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "olmesartan"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "AGTR1"
          }
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "MeSHDisease"
      ]
     },
     {
      "unset": [
       "Species"
      ]
     },
     {
      "set": {
       "Species": [
        "10116"
       ]
      }
     },
     {
      "set": {
       "MeSHAnatomy": [
        "Heart"
       ]
      }
     },
     {
      "set": {
       "MeSHDisease": [
        "Myocardial Infarction"
       ]
      }
     },
     {
      "set": {
       "Timeline": [
        "28 days"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "losartan"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "RGD",
         "name": "Ace2"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "olmesartan"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "RGD",
         "name": "Ace2"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Timeline"
      ]
     },
     {
      "unset": [
       "MeSHAnatomy"
      ]
     },
     {
      "unset": [
       "MeSHDisease"
      ]
     },
     {
      "unset": [
       "Species"
      ]
     },
     {
      "evidence": "Losartan was also shown to upregulate renal ACE2 expression in chronically treated rats (Klimas et al., 2015). In agreement with these observations, higher urinary ACE2 levels were observed in hypertensive patients treated with the AT1R antagonist olmesartan (Furuhashi et al., 2015)."
     },
     {
      "set": {
       "Species": [
        "10116"
       ]
      }
     },
     {
      "set": {
       "MeSHAnatomy": [
        "Kidney"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "losartan"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "RGD",
         "name": "Ace2"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "MeSHAnatomy"
      ]
     },
     {
      "unset": [
       "Species"
      ]
     },
     {
      "set": {
       "Species": [
        "9606"
       ]
      }
     },
     {
      "set": {
       "MeSHAnatomy": [
        "Urine"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "olmesartan"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "ACE2"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "MeSHAnatomy"
      ]
     },
     {
      "unset": [
       "Species"
      ]
     },
     {
      "evidence": "Taken together, these observations suggest that chronic AT1R blockade results in ACE2 upregulation in both rats and humans."
     },
     {
      "set": {
       "Species": [
        "9606"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "AGTR1"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "ACE2"
          }
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Species"
      ]
     },
     {
      "set": {
       "Species": [
        "10116"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "RGD",
           "name": "Agtr1a"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "RGD",
           "name": "Ace2"
          }
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Species"
      ]
     },
     {
      "evidence": "It has been demonstrated that the binding of the coronavirus spike protein to ACE2, its cellular binding site, leads to ACE2 downregulation, which in turn results in excessive production of angiotensin by the related enzyme ACE, while less ACE2 is capable of converting it to the vasodilator heptapeptide angiotensin 1\u20137."
     },
     {
      "set": {
       "Species": [
        "9606"
       ]
      }
     },
     {
      "set": {
       "Custom_Disease": [
        "COVID-19"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "complex"
        }
       },
       [
        [
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "COVID",
            "name": "S"
           }
          ]
         ],
         [
          {
           "function": {
            "type": "abundance",
            "name": "protein"
           }
          },
          [
           {
            "namespace": "HGNC",
            "name": "ACE2"
           }
          ]
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "ACE2"
          }
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "ACE2"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "angiotensin II"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "ACE2"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "ACE"
          }
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "This in turn contributes to lung injury, as angiotensin-stimulated AT1R results in increased pulmonary vascular permeability, thereby mediating increased lung pathology (Imai et al., 2005; Kuba et al., 2005)."
     },
     {
      "set": {
       "MeSHAnatomy": [
        "Lung"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "angiotensin II"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "AGTR1"
          }
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "AGTR1"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "GO",
         "name": "lung epithelium development"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "GO",
         "name": "lung epithelium development"
        }
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Lung Injury"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Therefore, higher ACE2 expression following chronically medicating SARS-CoV-2 infected patients with AT1R blockers, while seemingly paradoxical, may protect them against acute lung injury rather than putting them at higher risk to develop SARS."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "angiotensin receptor antagonist"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "HGNC",
         "name": "ACE2"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "ACE2"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Lung Injury"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "MeSHAnatomy"
      ]
     },
     {
      "evidence": "This may be accounted for by two complementary mechanisms: blocking the excessive angiotensin-mediated AT1R activation caused by the viral infection, as well as upregulating ACE2, thereby reducing angiotensin production by ACE and increasing the production of the vasodilator angiotensin 1\u20137."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     },
     {
      "relation": "positive_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "angiotensin II"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "angiotensin II"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "AGTR1"
          }
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "ACE2"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "ACE"
          }
         ]
        ]
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "ACE2"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "angiotensin II"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "ACE"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "Angiotensin I"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "process",
         "name": "activity"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "protein"
          }
         },
         [
          {
           "namespace": "HGNC",
           "name": "ACE2"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "PUBCHEM",
         "name": "123805"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "PUBCHEM",
         "name": "123805"
        }
       ]
      ]
     },
     {
      "relation": "increases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "biological_process"
        }
       },
       [
        {
         "namespace": "GO",
         "name": "vasodilation"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Losartan, telmisartan, olmesartan (and additional AT1R antagonists) are widely applied in the clinic since the 1990s for control of hypertension and kidney disorders, and are known as safe drugs that are rarely implicated in adverse drugs events (Deppe, B\u00f6ger, Weiss, & Benndorf, 2010; McIntyre, Caffe, Michalak, & Reid, 1997)."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "losartan"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "hypertension"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "losartan"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "kidney disease"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "telmisartan"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "hypertension"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "telmisartan"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "kidney disease"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "olmesartan"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "hypertension"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "olmesartan"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "kidney disease"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "If the latter percentage would be found to be significantly smaller, this would support the notion that AT1R antagonists confer protection from severe symptoms among SARS-CoV-2 infected individuals."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "angiotensin receptor antagonist"
        }
       ]
      ]
     },
     {
      "relation": "negative_correlation"
     },
     {
      "object": [
       {
        "function": {
         "type": "process",
         "name": "pathology"
        }
       },
       [
        {
         "namespace": "DO",
         "name": "COVID-19"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Custom_Disease"
      ]
     },
     {
      "unset": [
       "Species"
      ]
     },
     {
      "unset": [
       "Section"
      ]
     },
     {
      "unset": [
       "PublicationStatus"
      ]
     },
     {
      "unset": [
       "PublicationType"
      ]
     },
     {
      "unset": [
       "Citation"
      ]
     }
    ]
   }
  ]
 }
]